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Editors’ NotesProgress in Pluripotency
It has been less than three years since Takahashi and Yamanaka demonstrated that viral transduction of the four-factor
cocktail of Oct4, KLF4, Sox2, and c-Myc transgenes was sufficient to convert fibroblasts into ESC-like cells. In this issue,
Ding, Scho¨ler, and coauthors demonstrate that providing cell-permeable versions of the same four proteins is sufficient,
with assistance from an HDAC inhibitor, to convert MEFs into iPSCs that contribute to all three germ layers of murine
chimeras, including the gonads. These protein-induced pluripotent stem cells (or piPSCs) represent an exciting advance
in the field of induced pluripotency, and the method provides a significant step toward potential
therapeutic applications for these cells by removing the risk of introducing genetic mutations. As
discussed by Huck-Hui Ng and colleagues in last month’s Review article (4: 301), the specific
role played by the addition of valproic acid remains open to question, but more generally, several
lines of evidence implicate a variety of chromatin modulators in regulation of the pluripotent
state. Providing another illustration of that overall theme, in this issue Buchholz and colleagues
describe a genome-wide RNAi screen from which they identified a collection of genes and cor-
responding pathways that influence the pluripotent state, including members of the transcription-
and chromatin-modifying Paf1 complex.
Tracking Down Tumors
Two papers in this issue supply new information about tumor-forming cells; human glioma samples are discussed in one
study, and murine models of dermal neurofibroma in the other. In the latter case, Parada and colleagues reveal that skin-
derived precursors (SKPs) represent a putative cell of origin for dermal fibromas and propose that
the broad range of NF1 mutant tumors observed in human patients may originate from distinct cell
populations. From a completely different angle, Fine and coauthors identify a hierarchy of subpopu-
lations within primary human glioma isolates and reveal not only that SSEA-1 expression marks the
xenograft tumor-forming fraction of samples, but also that this population is present in almost all
samples examined—in contrast to the less prevalent CD133+ population. Advances in identifying
a population of origin, as in the Parada paper, or in how to identify tumor-initiating cells in existing
cancers are both important steps toward understanding the cellular basis of tumors and thus, hope-
fully, designing new therapeutic approaches.
Revealing Regulatory Relationships
The sheer number of expressible genes means that individual cell states are defined by multiple different networks of
interacting proteins, and that many different regulatory or expression changes can impact a given state. The Review
article in this issue, from Andrews and coauthors, outlines how the imagery of balls moving
through an undulating landscape can be used to visualize, and indeed model, the relationships
that exist between these regulatory networks. By considering data from both embryonic and
hematopoietic systems, the authors offer insights into how to connect existing findings and
also emphasize the power of applying network modeling to the design of future experiments.
An example of regulatory network modulation can be found in the small-molecule screen
published this month by Schultz and colleagues, who identify a small molecule, stauprimide,
that enhances the effectiveness of lineage-specific differentiation cues. The mechanism of action
appears to involve reduction of c-Myc expression, leaving the exposed ESCs, both mouse and
human, primed to respond to additional signaling stimulation.
Election Events, Past and Present
Toward the end of last month, in the US, President Obama’s administration made further progress on one of his
campaign promises to relieve restrictions on human embryonic cell research by releasing a draft set of NIH guidelines
for a 30-day public comment period (see http://stemcells.nih.gov/policy/2009draft/). This month, in its dedicated Cell
Stem Cell section, the ISSCR announces the results of its 2009 elections, with a number of new faces joining the society
leadership. In her Executive Note, Nancy Witty thanks previous contributors who are now stepping down and congrat-
ulates elected members as they take up their new positions.
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